<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kirkemo LL</submitter><funding>Chan Zuckerberg Biohub Investigator Program</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>Harry and Dianna Hind Professorship</funding><funding>NIGMS NIH HHS</funding><funding>National Science Foundation</funding><pagination>e73982</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8983049</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11</volume><pubmed_abstract>Characterization of cell surface proteome differences between cancer and healthy cells is a valuable approach for the identification of novel diagnostic and therapeutic targets. However, selective sampling of surface proteins for proteomics requires large samples (>10e6 cells) and long labeling times. These limitations preclude analysis of material-limited biological samples or the capture of rapid surface proteomic changes. Here, we present two labeling approaches to tether exogenous peroxidases (APEX2 and HRP) directly to cells, enabling rapid, small-scale cell surface biotinylation without the need to engineer cells. We used a novel lipidated DNA-tethered APEX2 (DNA-APEX2), which upon addition to cells promoted cell agnostic membrane-proximal labeling. Alternatively, we employed horsera</pubmed_abstract><journal>eLife</journal><pubmed_title>Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells.</pubmed_title><pmcid>PMC8983049</pmcid><funding_grant_id>R35 GM122451</funding_grant_id><funding_grant_id>U01 CA244452</funding_grant_id><funding_grant_id>F31 CA247527</funding_grant_id><funding_grant_id>R01CA248323</funding_grant_id><funding_grant_id>1F31CA247527</funding_grant_id><funding_grant_id>U01CA244452</funding_grant_id><funding_grant_id>R01 CA248323</funding_grant_id><funding_grant_id>1650113</funding_grant_id><funding_grant_id>R35GM122451</funding_grant_id><pubmed_authors>Blelloch R</pubmed_authors><pubmed_authors>Kirkemo LL</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Glasgow JE</pubmed_authors><pubmed_authors>Byrnes JR</pubmed_authors><pubmed_authors>Elledge SK</pubmed_authors><pubmed_authors>Wells JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells.</name><description>Characterization of cell surface proteome differences between cancer and healthy cells is a valuable approach for the identification of novel diagnostic and therapeutic targets. However, selective sampling of surface proteins for proteomics requires large samples (>10e6 cells) and long labeling times. These limitations preclude analysis of material-limited biological samples or the capture of rapid surface proteomic changes. Here, we present two labeling approaches to tether exogenous peroxidases (APEX2 and HRP) directly to cells, enabling rapid, small-scale cell surface biotinylation without the need to engineer cells. We used a novel lipidated DNA-tethered APEX2 (DNA-APEX2), which upon addition to cells promoted cell agnostic membrane-proximal labeling. Alternatively, we employed horsera</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-05-31T01:04:14.913Z</modification><creation>2025-04-04T11:31:49.19Z</creation></dates><accession>S-EPMC8983049</accession><cross_references><pubmed>35257663</pubmed><doi>10.7554/eLife.73982</doi></cross_references></HashMap>